Feed ARX
AR

Accelerant Holdings ARX · NYSE

$19.77 +0.05% (+$0.01)

Summary

44 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 60% a year over the last 3 years.
  • Analysts expect revenue to grow by 30% this fiscal year.
  • It bought back its own shares for $175.3M in the last fiscal year, 4.1% of its market value.

What to watch

  • The company made a loss over the last 12 months.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 60% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 30%.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $1.30B.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $17.75 is 10% below today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Underwriting Segment brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy